From CBC News:
The manufacturer of a drug for treating Type 2 diabetes has placed new restrictions on use of the medication based on a Health Canada review of clinical data pointing to an increased risk of heart-related problems in some patients.
GlaxoSmithKline Inc., in consultation with Health Canada, is updating prescribing information on products made from or containing the drug rosiglitazone: Avandia, Avandamet and AvandarylTM.
Once touted as the gold standard for preventing Type 2 diabetes in high-risk patients, rosiglitazone lost its glitter after a study published in the New England Journal of Medicine in May showed Avandia significantly raised the risk of heart attack and possible death. ...more
Thursday, November 08, 2007
Manufacturer restricts use of diabetes drug Avandia
Labels:
Avandamet,
Avandia,
Avandryl,
Health Canada warning,
rosiglitazone
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment